Sterling Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Sterling Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,343	Closed	-$1.1M	–	59
2024 Q1	$1.1M	Sell	20,343 -435	-2%	-$22.2K	0.78%	38
2023 Q4	$1.07M	Sell	20,778 -410	-2%	-$21.5K	0.78%	40
2023 Q3	$1.23M	Sell	21,188 -350	-2%	-$21.4K	1.09%	27
2023 Q2	$1.38M	Sell	21,538 -312	-1%	-$20.9K	1.09%	28
2023 Q1	$1.51M	Sell	21,850 -295	-1%	-$20.8K	1.21%	26
2022 Q4	$1.59M	Sell	22,145 -1,334	-6%	-$101K	1.28%	27
2022 Q3	$1.67M	Buy	23,479 +5,328	+29%	+$386K	1.41%	23
2022 Q2	$1.4M	Sell	18,151 -1,499	-8%	-$114K	1.16%	26
2022 Q1	$1.44M	Sell	19,650 -4,288	-18%	-$288K	1.01%	30
2021 Q4	$1.49M	Sell	23,938 -937	-4%	-$55K	0.93%	39
2021 Q3	$1.47M	Buy	24,875 +1,051	+4%	+$69.2K	0.94%	37
2021 Q2	$1.59M	Buy	23,824 +1,026	+5%	+$66.9K	1.04%	30
2021 Q1	$1.44M	Buy	+22,798	New	+$1.42M	0.98%	34

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sterling Investment Management's BMY Position: Q2 2024 in Review

Sterling Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 20,343 shares — an estimated $1.1M sold.

Sterling Investment Management first reported a position in BMY in Q1 2021 and held it in 13 quarters. The position peaked at $1.67M in Q3 2022. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Sterling Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Sterling Investment Management sold 20,343 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.1M.
Sterling Investment Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 13 quarters.
Sterling Investment Management's Bristol-Myers Squibb position peaked at $1.67M in Q3 2022.
2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Sterling Investment Management's 13F filing for Q2 2024, filed 26 Jul 2024.